GASTROINTESTINAL PARAMETERS THAT INFLUENCE ORAL MEDICATIONS

被引:53
作者
DRESSMAN, JB
BASS, P
RITSCHEL, WA
FRIEND, DR
RUBINSTEIN, A
ZIV, E
机构
[1] UNIV WISCONSIN,SCH PHARM,MADISON,WI 53706
[2] UNIV CINCINNATI,MED CTR,DIV PHARMACEUT & DRUG DELIVERY SYST,CINCINNATI,OH 45267
[3] SRI INT,MENLO PK,CA 94025
[4] HEBREW UNIV JERUSALEM,SCH PHARM,IL-91170 JERUSALEM,ISRAEL
[5] HADASSAH UNIV HOSP,DIABET UNIT,IL-91120 JERUSALEM,ISRAEL
关键词
D O I
10.1002/jps.2600820902
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The successful functioning of oral medication depends primarily on how the gastrointestinal (GI) tract processes drugs and drug delivery systems. Parameters such as regional pH, motility (and hence residence time), and brush border and colonic microflora enzymatic activity play an important role in the performance of orally administered dosage forms. In addition, medications are required to treat disease states that alter normal functions of the body. This review (which summarizes the symposium of the same title undertaken in the 2nd Jerusalem Conference on Pharmaceutical Sciences and Clinical Pharmacology, Jerusalem, Israel, May 1992) focuses on two aspects: (1) how some physiological parameters of the intestine can be manipulated to achieve control over drug absorption (P. Bass: alteration of the paracellular space of enterocytes with glucose to modulate the passive movement of drugs; E. Ziv: intestinal absorption af insulin) and spatial placement of drugs (D. R. Friend: use of colonic beta-glucosidases to target glycoside prodrugs of steroids to the large bowel; A. Rubinstein: specific degradation of polysaccharide matrices by colonic bacteria); and (2) how degradation of the GI tract affect drug performance (J. B. Dressman: physiological and pathophysiological changes in upper GI tract pH may lead to alterations in drug bioavailability; W. A. Ritschel: influence of diseases on the pharmacokinetics of drugs).
引用
收藏
页码:857 / 872
页数:16
相关论文
共 101 条
  • [1] PHARMACOKINETICS OF TRANEXAMIC ACID IN PATIENTS WITH ULCERATIVE-COLITIS AND IN HEALTHY-VOLUNTEERS AFTER THE SINGLE INSTILLATION OF 2G RECTALLY
    ALMER, S
    ANDERSSON, T
    STROM, M
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 32 (01) : 49 - 54
  • [2] DRUG ABSORPTION AND HEPATIC DRUG-METABOLISM IN PATIENTS WITH DIFFERENT TYPES OF INTESTINAL SHUNT OPERATION FOR OBESITY - STUDY WITH PHENAZONE
    ANDREASEN, PB
    DANO, P
    KIRK, H
    GREISEN, G
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1977, 12 (05) : 531 - 535
  • [3] ANTHONISEN P, 1974, SCAND J GASTROENTERO, V9, P549
  • [4] MALABSORPTION OF HYDROCHLOROTHIAZIDE FOLLOWING INTESTINAL SHUNT SURGERY
    BACKMAN, L
    BEERMAN, B
    GROSCHINSKYGRIND, M
    HALLBERG, D
    [J]. CLINICAL PHARMACOKINETICS, 1979, 4 (01) : 63 - 68
  • [5] PROTEIN A-GOLD ELECTRON-MICROSCOPIC IMMUNOCYTOCHEMISTRY - METHODS, APPLICATIONS, AND LIMITATIONS
    BENDAYAN, M
    [J]. JOURNAL OF ELECTRON MICROSCOPY TECHNIQUE, 1984, 1 (03): : 243 - 270
  • [6] MORPHO-CYTOCHEMICAL AND BIOCHEMICAL-EVIDENCE FOR INSULIN ABSORPTION BY THE RAT ILEAL EPITHELIUM
    BENDAYAN, M
    ZIV, E
    BENSASSON, R
    BARON, H
    KIDRON, M
    [J]. DIABETOLOGIA, 1990, 33 (04) : 197 - 204
  • [7] ELEVATION OF GASTRIC PH WITH RANITIDINE DOES NOT AFFECT THE RELEASE CHARACTERISTICS OF SUSTAINED-RELEASE IBUPROFEN TABLETS
    BERARDI, RR
    DRESSMAN, JB
    ELTA, GH
    SZPUNAR, GJ
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 1988, 9 (04) : 337 - 347
  • [8] BEYSSAC E, 1991, METHOD FIND EXP CLIN, V13, P565
  • [9] GLUCOSE AND CITRATE REDUCE THE PERMEABILITY CHANGES CAUSED BY INDOMETHACIN IN HUMANS
    BJARNASON, I
    SMETHURST, P
    MACPHERSON, A
    WALKER, F
    MCELNAY, JC
    PASSMORE, AP
    MENZIES, IS
    [J]. GASTROENTEROLOGY, 1992, 102 (05) : 1546 - 1550
  • [10] INCREASED GASTRIC PH AND THE BIOAVAILABILITY OF FLUCONAZOLE AND KETOCONAZOLE
    BLUM, RA
    DANDREA, DT
    FLORENTINO, BM
    WILTON, JH
    HILLIGOSS, DM
    GARDNER, MJ
    HENRY, EB
    GOLDSTEIN, H
    SCHENTAG, JJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 114 (09) : 755 - 757